ARTICLE | Financial News
The Column Group targeting $250 million for second fund
April 15, 2014 11:30 PM UTC
Biotech VC firm The Column Group has raised $175.9 million of a planned $250 million for its second fund, according to an SEC filing. The firm could not be reached for details in time for publication....